XML 75 R65.htm IDEA: XBRL DOCUMENT v3.24.3
Commitments and Contingencies - Additional Information (Detail)
€ in Millions
 1 Months Ended 9 Months Ended 12 Months Ended 48 Months Ended
Oct. 10, 2024
USD ($)
Dec. 31, 2023
USD ($)
Nov. 09, 2022
USD ($)
Jun. 02, 2022
USD ($)
Jul. 31, 2024
Jul. 31, 2023
USD ($)
Jun. 30, 2023
USD ($)
Sep. 30, 2013
USD ($)
Apr. 30, 2013
USD ($)
Sep. 30, 2024
USD ($)
Sep. 30, 2021
USD ($)
Dec. 31, 2023
USD ($)
Aug. 21, 2022
USD ($)
Oct. 31, 2024
USD ($)
Oct. 31, 2024
EUR (€)
Jun. 30, 2024
USD ($)
Mar. 28, 2024
USD ($)
Dec. 31, 2023
EUR (€)
Aug. 21, 2023
USD ($)
Jul. 08, 2021
USD ($)
Aug. 31, 2019
USD ($)
Jul. 31, 2008
USD ($)
Feb. 28, 2005
USD ($)
Commitment And Contingencies [Line Items]                                              
Annual sales at the time of settlement                               $ 700,000,000         $ 350,000,000    
Annual sales of Effexor                         $ 2,600,000,000                    
Annual sales of Lamictal                                           $ 2,300,000,000 $ 950,000,000
Annual sales of Niaspan               $ 1,100,000,000 $ 416,000,000                            
Litigation settlement amount             $ 4,250,000,000     $ 495,000,000                          
Litigation settlement amount awarded distribution period             13 years                                
Generic modafinil, and imposed fines amount   $ 4,771,000,000               4,915,000,000   $ 4,771,000,000           € 60.5          
Loss Contingency Accrual, Provision   235,500,000                                          
Annual sales of the time of settlement of viread                   582,000,000                          
Annual sales of the time of settlement of Truvada                   2,400,000,000                          
Annual sales of the time of settlement of Atripla                   2,900,000,000                          
Annual sales of the time of New launch of viread                   728,000,000                          
Annual sales of the time of New launch of Truvada                   2,100,000,000                          
Annual sales of the time of New launch of Atripla                   444,000,000                          
Litigation Settlement Amount Distributable In Kind                               1,200,000,000              
Accrual for Environmental Loss Contingencies                               $ 300,000              
Loss Contingencies On Environmental Laws Penalty                                       $ 1,400,000      
Litigation Settlement amount payable year one                   35,000,000                          
Litigation settlement amount payable remainder of fiscal year                   80,000,000                          
Other commitment                                 $ 150,000,000            
Annual Sales Of Revlimid                   $ 3,500,000,000                          
Annual Sales At The Time Of Nuvigil Entered Into First Settlement Of With AN ANDA Filer   300,000,000                                          
Loss Contingency Claims Dismissed Value Paid To Each State Proportional To Its Share Of National Population   $ 1,000,000                                          
Percentage Of Share Of The National Population   1.00%                                          
Percentgae of amount in cash settlement                               20.00%              
Litigation Settlement Amount Distributable in cash                               $ 240,000,000              
Loss Contingency, Damages Awarded, Value     $ 176,500,000                                        
Maximum [Member]                                              
Commitment And Contingencies [Line Items]                                              
Damage claimed                       $ 1,000,000,000                      
Deferred Prosecution Agreement With U.S. Department of Justice [Member] | Donation of Clotrimazole and Tobramycin [Member]                                              
Commitment And Contingencies [Line Items]                                              
Other commitment                                     $ 50,000,000        
Deferred Prosecution Agreement With U.S. Department of Justice [Member] | Fine for Violating the Antitrust Laws [Member]                                              
Commitment And Contingencies [Line Items]                                              
Other commitment, to be paid, year five                                     135,000,000        
Other commitment to pay for each year                                     22,500,000        
Other commitment                                     $ 225,000,000        
Subsequent Event [Member]                                              
Commitment And Contingencies [Line Items]                                              
Litigation fine amount of copaxone                           $ 500,000,000 € 462.6                
Opioid Litigation [Member]                                              
Commitment And Contingencies [Line Items]                                              
Loss contingency accrual, product liability, undiscounted, to be paid, year five                               390,000,000              
Loss contingency accrual, product liability, undiscounted, to be paid, year four                               374,000,000              
Loss contingency accrual, product liability, undiscounted, to be paid, year three                               368,000,000              
Loss contingency accrual, product liability, undiscounted, to be paid, year two                               423,000,000              
Loss contingency accrual, product liability, undiscounted, to be paid, year one                               428,000,000              
Modafinil Settlement Agreement [Member]                                              
Commitment And Contingencies [Line Items]                                              
Settlement as a percentage of aggregate subdivisions and tribes                   100.00%                          
Loss contingency aggregate payments paid                               $ 392,000,000              
Civil Action In Respect Of Donations To Patient Assistance Programmers [Member] | Subsequent Event [Member]                                              
Commitment And Contingencies [Line Items]                                              
Generic modafinil, and imposed fines amount $ 425,000,000                                            
Loss contingency accrual due in fifth year 175,000,000                                            
Loss contingency accrual due in fourth year 99,000,000                                            
Loss contingency accrual due in third year 49,000,000                                            
Loss contingency accrual due in second year 49,000,000                                            
Loss contingency accrual next twelve months 34,000,000                                            
Loss contingency accrual remainder of fiscal year 19,000,000                                            
Civil Investigative Demand From Department Of Justice Civil Division [Member] | Subsequent Event [Member]                                              
Commitment And Contingencies [Line Items]                                              
Generic modafinil, and imposed fines amount 25,000,000                                            
Loss Contingency Accrual, Provision 25,000,000                                            
Civil Investigative Demand From Department Of Justice Civil Division [Member] | Subsequent Event [Member] | Two Thousand And Twenty Five [Member]                                              
Commitment And Contingencies [Line Items]                                              
Loss contingency accrual current 15,000,000                                            
Civil Investigative Demand From Department Of Justice Civil Division [Member] | Subsequent Event [Member] | Two Thousand And Twenty Four [Member]                                              
Commitment And Contingencies [Line Items]                                              
Loss contingency accrual current $ 10,000,000                                            
Ontario Teachers Securities Litigation [Member] | Settled Litigation [Member]                                              
Commitment And Contingencies [Line Items]                                              
Litigation settlement amount       $ 420,000,000                                      
Litigation With US Hospitals And Other Healthcare Providers [Member]                                              
Commitment And Contingencies [Line Items]                                              
Litigation settlement amount           $ 126,000,000                                  
Litigation settlement amount awarded distribution period         18 years                                    
Product WAC Value           $ 49,000,000                                  
Product WAC Term           7 years                                  
Europe [Member]                                              
Commitment And Contingencies [Line Items]                                              
Damage claimed                     $ 50,000,000                        
Eosinophilic Esophagitis [Member]                                              
Commitment And Contingencies [Line Items]                                              
Damage claimed                     200,000,000                        
Eosinophilic Esophagitis [Member] | United States [Member]                                              
Commitment And Contingencies [Line Items]                                              
Damage claimed                     $ 150,000,000                        
AndroGel Rate at 1% [Member]                                              
Commitment And Contingencies [Line Items]                                              
Annual sales at the time of settlement                                         $ 140,000,000